Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon B Mills

Showing results (171-180 of 826) with videos related to

Pageof 83
Sort By:
BMC Bioinformatics|December 24, 2008
RPPAML/RIMS: a metadata format and an information management system for reverse phase protein arraysRomesh Stanislaus, Mark Carey, Helena F Deus, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 4, 2012
Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencingBojana Djordjevic, Bryan T Hennessy, Jie Li, et al.
Advances in Experimental Medicine and Biology|June 13, 2008
Individualized molecular medicine: linking functional proteomics to select therapeutics targeting the PI3K pathway for specific patientsMandi M Murph, Debra L Smith, Bryan Hennessy, et al.
Cancer Research|September 7, 2007
Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximabYang Lu, Xinqun Li, Ke Liang, et al.
Oncogene|April 18, 2002
Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signalingMacus Tien Kuo, Zesheng Liu, Yingjie Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancerZhensheng Liu, Li-E Wang, Luo Wang, et al.
Cancer Research|October 3, 2008
Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma modelLaura A Lambert, Na Qiao, Kelly K Hunt, et al.
Cancer Research|March 2, 2016
Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer CellsKimberly S Lucenay, Iman Doostan, Cansu Karakas, et al.
Nature Communications|May 27, 2024
C5aR1 inhibition reprograms tumor associated macrophages and reverses PARP inhibitor resistance in breast cancerXi Li, Alfonso Poire, Kang Jin Jeong, et al.
Cell Death & Disease|August 18, 2023
Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancerSoon Young Park, Kang Jin Jeong, Alfonso Poire, et al.
Pageof 83

Showing results (171-180 of 826) with videos related to

Sort By:
Pageof 83
BMC Bioinformatics|December 24, 2008
RPPAML/RIMS: a metadata format and an information management system for reverse phase protein arraysRomesh Stanislaus, Mark Carey, Helena F Deus, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 4, 2012
Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencingBojana Djordjevic, Bryan T Hennessy, Jie Li, et al.
Advances in Experimental Medicine and Biology|June 13, 2008
Individualized molecular medicine: linking functional proteomics to select therapeutics targeting the PI3K pathway for specific patientsMandi M Murph, Debra L Smith, Bryan Hennessy, et al.
Cancer Research|September 7, 2007
Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximabYang Lu, Xinqun Li, Ke Liang, et al.
Oncogene|April 18, 2002
Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signalingMacus Tien Kuo, Zesheng Liu, Yingjie Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancerZhensheng Liu, Li-E Wang, Luo Wang, et al.
Cancer Research|October 3, 2008
Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma modelLaura A Lambert, Na Qiao, Kelly K Hunt, et al.
Cancer Research|March 2, 2016
Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer CellsKimberly S Lucenay, Iman Doostan, Cansu Karakas, et al.
Nature Communications|May 27, 2024
C5aR1 inhibition reprograms tumor associated macrophages and reverses PARP inhibitor resistance in breast cancerXi Li, Alfonso Poire, Kang Jin Jeong, et al.
Cell Death & Disease|August 18, 2023
Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancerSoon Young Park, Kang Jin Jeong, Alfonso Poire, et al.
Pageof 83